Program

1:30 pm – 2:00 pm

Registration

2:00 pm: Welcome addresses

  • Dr Franck Dufour, ARC Foundation Scientific director, Villejuif, France
  • Prof. Jules Hoffmann President of the jury, Institute of Molecular and Cellular Biology, Strasbourg, France

2:05 pm – 4:10 pm

Attending speakers:

  • Prof. Riccardo Dalla-Favera, Institute for Cancer Genetics at Columbia University, New York, USA
    The makings of Human B Cell Lymphoma
  • Prof. Michel Cogné, University of Limoges, Limoges France
    How an IgH super-enhancer governs B-cell fate
  • Prof. Brunangelo Falini, University of Perugia, Perugia, Italy
    Hairy cell leukemia: from hairiness to BRAF inhibitors
  • Prof. Pierre Brousset, IUCT Oncopole, Toulouse, France
    Impact of expert pathological review on lymphoma clinical management:  experience of the French Lymphopath Network

4:10 pm – 4:35 pm: Break

4:35 pm – 6:25 pm

Attending speakers:

  • Prof. Richard Marais, CRUK Manchester Institute, Manchester, UK
    Translating basic research discoveries into precision medicine and improved outcomes in melanoma patients
  • Prof. Caroline Robert, Gustave Roussy, Villejuif, France
    Treatment of melanoma: more than one signaling pathway involved
  • Prof. Richard Treisman, Francis Crick Institute, London, UK
    Probing the transcriptional consequences of Ras and Rho activation
  • Prof. Anton Berns, Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Mouse models of lung cancer

6:25 pm: Conclusion – Michel Pébereau (President of the ARC Foundation) 

7:00 pm – 9:00 pm: Ceremony & Cocktail